Literature DB >> 18212771

Surgery Insight: percutaneous treatment of prosthetic paravalvular leaks.

Ravinay Bhindi1, Sacha Bull, Ryan G Schrale, Neil Wilson, Oliver J Ormerod.   

Abstract

Serious paravalvular leakage occurs in 1-5% of patients who have undergone surgical cardiac valve replacement procedures. Clinical manifestations include hemolysis, heart failure and arrhythmias. Presently, the gold standard treatment for severe paravalvular leakage is surgery; however, the outcomes remain far from optimum. In this Review we discuss the problem of paravalvular leak and focus on the role of percutaneous repair as a treatment option.

Entities:  

Mesh:

Year:  2008        PMID: 18212771     DOI: 10.1038/ncpcardio1112

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  2 in total

1.  Closure of a para-valvular aortic leak: with the use of 2 AMPLATZER devices and real-time 2- and 3-dimensional transesophageal echocardiography.

Authors:  Kurt S Hoffmayer; Christian Zellner; Damon M Kwan; Suma Konety; Elyse Foster; Phillip Moore; Yerem Yeghiazarians
Journal:  Tex Heart Inst J       Date:  2011

2.  A case demonstrating a percutaneous closure using the amplatzer duct occluder for paravalvular leakage after tricuspid valve replacement.

Authors:  Young Hee Heo; Soo-Jin Kim; Sang Yun Lee; Jae Suk Baek
Journal:  Korean Circ J       Date:  2013-04-30       Impact factor: 3.243

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.